3D ultrasound could spot leftover skin cancer cells right after surgery

NCT ID NCT07402616

Recruiting now Diagnosis Sponsor: Rigshospitalet, Denmark Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explores whether a 3D ultrasound scan of removed skin cancer tissue can accurately measure how deep the tumor goes. Researchers will compare ultrasound images to standard lab analysis. If it works, this technique might help surgeons know immediately if they got all the cancer out, possibly avoiding repeat surgeries. The study involves 30 adults with a common type of skin cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ex vivo 3D ultrasonography
What this could lead to: If successful, this could provide a faster, non-invasive way to check if all cancer was removed during surgery, reducing the need for second operations.
What could go wrong: This is a small, early feasibility study with only 30 participants. The ultrasound method may not match the accuracy of standard pathology, and results may not apply to all skin cancer types or locations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CUTANEOUS SQUAMOUS CELL CARCINOMA

Contacts and locations

Locations

Rigshospitalet
RECRUITING

Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.